Myeloproliferative neoplasms with concurrent BCR–ABL1 translocation and JAK2 V617F mutation: a multi-institutional study from the bone marrow pathology group
Modern Pathology2018Vol. 31(5), pp. 690–704
Citations Over TimeTop 10% of 2018 papers
Craig Soderquist, Mark D. Ewalt, David R. Czuchlewski, Julia T. Geyer, Heesun J. Rogers, Eric D. Hsi, Sa A. Wang, Carlos E. Bueso‐Ramos, Attilio Orazi, Daniel A. Arber, Elizabeth O. Hexner, Daria V. Babushok, Adam Bagg
Related Papers
- → Cutaneous extramedullary hematopoiesis in myelofibrosis(1990)45 cited
- → Modern management of splenomegaly in patients with myelofibrosis(2020)37 cited
- → Cutaneous Myelofibrosis With JAK2 V617F Mutation: Metastasis, Not Merely Extramedullary Hematopoiesis!(2010)15 cited
- → Treatment of anemia in myelofibrosis: focusing on novel therapeutic options(2023)3 cited
- → Peri-Renal Extramedullary Hematopoiesis in Primary Myelofibrosis Patient.(2022)